Sulfobutylether-β-cyclodextrin: A functional biopolymer for drug delivery applications

Chandrakantsing V. Pardeshi, Rucha V. Kothawade, Ashwini R. Markad, Sagar R. Pardeshi, Abhijeet D. Kulkarni, Prashant J. Chaudhari, Marcela R. Longhi, Namdev Dhas, Jitendra B. Naik, Sanjay J. Surana, Mónica C. García

Research output: Contribution to journalReview articlepeer-review

Abstract

Sulfobutylether β-cyclodextrin (SBE-β-CD) is a polyanionic cyclic oligosaccharide that contains glucopyranose units forming a torus ring-like structure. SBE-β-CD is gifted with many favorable properties viz. relatively high solubility (>50 folds compared to β-CD), improved stability, and biocompatibility that praised SBE-β-CD as a smart polymer for drug delivery applications. Commercially, SBE-β-CD is popular by its brand name Captisol®. The present review discusses the structure, properties, and preparation methods of SBE-β-CD-based inclusion complexes (ICs). Furthermore, we discuss here the preparation and applications of SBE-β-CD ICs-based nanoparticulate drug delivery systems, which combines the merits of both, ICs (enhanced solubility) and nanoparticles (NPs, targeted therapy). Patents on and FDA-approved Captisol®-enabled products are tabulated in the benefit of readers. The toxicological aspects and current clinical status of SBE-β-CD or SBE-β-CD-based products are briefly explained in the present review. In our opinion, the present review would be a pathfinder to allow dissemination of information on SBE-β-CD.

Original languageEnglish
Article number120347
JournalCarbohydrate Polymers
Volume301
DOIs
Publication statusPublished - 01-02-2023

All Science Journal Classification (ASJC) codes

  • Polymers and Plastics
  • Organic Chemistry
  • Materials Chemistry

Fingerprint

Dive into the research topics of 'Sulfobutylether-β-cyclodextrin: A functional biopolymer for drug delivery applications'. Together they form a unique fingerprint.

Cite this